Ara
Toplam kayıt 166, listelenen: 61-70
Efficacy and safety profile of COVID-19 vaccine in cancer patients: A prospective, multicenter cohort study
(Future Medicine Ltd, 2022)
Aim: To compare the seropositivity rate of cancer patients with non-cancer controls after inactive SARS-CoV-2 vaccination (CoronaVac) and evaluate the factors affecting seropositivity. Method: Spike IgG antibodies against ...
Robotic Process Automation (RPA) applications in COVID-19
(Springer Science and Business Media Deutschland GmbH, 2021)
The COVID-19 pandemic took the entire world by surprise. Governments and companies hastily implemented measures to protect public health as well as the countries’ economies. Many companies had to close their offices and ...
Defining appropriate government strategies to reduce unemployment during COVID-19 pandemics
(Springer Science and Business Media Deutschland GmbH, 2021)
The unemployment problem became more significant, especially after COVID-19 pandemics. This situation affected both developing and developed countries in a negative manner. Hence, the policies implemented by the states to ...
Anxiety levels of community pharmacists during the COVID-19 pandemic: A crosssectional study in Istanbul
(Hacettepe University, Faculty of Pharmacy, 2021)
Community pharmacists have been on the frontlines during the 2019 Coronavirus Disease (COVID-19) pandemic. Although the mental health and anxiety levels of many other health workers are studied in this period, literature ...
Higher rates of COVID-19 but less severe infections reported for patients on dupilumab: A big data analysis of the world health organization vigibase
(Verduci Editore s.r.l, 2021)
Objective: Dupilumab (Dupixent ®) is a monoclonal antibody that inhibits IL- 4 and IL-13 signaling used for the treatment of allergic diseases. Whilst biologic therapy is traditionally regarded as immunosuppressive and ...
Headache onset after vaccination against SARS-CoV-2: A systematic literature review and meta-analysis
(BMC, 2022)
Background Vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) are used to reduce the risk of developing Coronavirus Disease 2019 (COVID-19). Despite the significant benefits in terms of reduced ...
From asymptomatic to critical illness: Decoding various clinical stages of COVID-19
(The Scientific and Technological Research Council of Turkey, 2021)
The clinical course of COVID-19 is variable, with clinical manifestation ranging from 81% mild course to 14% severe course along with 5% critical course in patients. The asymptomatic course is reported to potentially range ...
Covid-19: Pathogenesis, genetic polymorphism, clinical features and laboratory findings
(TUBITAK Scientific & Technological Research Council of Turkey, 2020)
COVID-19 caused by a novel agent SARS-CoV-2 progressed to a pandemic condition and resulted in a major public health concern worldwide, leading to social and economic issues at the same time. The pathogenesis of COVID-19 ...
Clinical characteristics and outcomes of COVID-19 in Turkish patients with hematological malignancies
(NLM (Medline), 2022)
Objective: Patients with solid malignancies are more vulnerable to severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) infection than the healthy population. The outcome of SARS-CoV-2 infection in highly ...
Analysis of the involvement of the thyroid gland using computed tomography in patients with suspected SARS-CoV-2 infection: A retrospective study
(Verduci Editore s.r.l, 2021)
OBJECTIVE: SARS-CoV-2 primarily infects the respiratory tract and leads to severe pneumonia by binding to the ACE-2 receptor. The virus can also interact with ACE-2 receptors expressed in other tissues as in thyroid. This ...